繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 耳鼻喉 >> 鼻炎 >> Astepro(盐酸氮卓斯汀鼻喷剂)

Astepro(盐酸氮卓斯汀鼻喷剂)

2011-03-28 18:54:36  作者:新特药房  来源:中国新特药网天津分站  浏览次数:368  文字大小:【】【】【
简介: 抗组胺鼻喷剂Astepro新剂型获准用于季节性过敏性鼻炎Meda制药公司在2009年9月2日宣布:美国食品药品管理局(FDA)已经批准0.15%浓度的抗组胺药Astepro(盐酸氮卓斯汀)鼻喷剂用于季节性鼻炎(SAR)和常年性鼻 ...

抗组胺鼻喷剂Astepro新剂型获准用于季节性过敏性鼻炎
Meda制药公司在2009年9月2日宣布:美国食品药品管理局(FDA)已经批准0.15%浓度的抗组胺药Astepro(盐酸氮卓斯汀)鼻喷剂用于季节性鼻炎(SAR)和常年性鼻炎(PAR)的症状治疗。该Astepro新剂型浓度比原剂型增加50%,每日1次,以方便季节性过敏性鼻炎患者服用。
美国FDA对0.15%浓度Astepro鼻喷剂的批准认证主要得到来自7项双盲、安慰剂对照、III期临床试验的数据支持。试验共纳入超过2,300例SAR和PAR患者,周期为2~4周不等,还包括一项长达12个月的药物安全性试验。在SAR 试验中,患者用0.15%浓度的Astepro鼻喷剂和安慰剂分别喷2次于左右鼻腔,每日1~2次。在PAR 试验中,患者用0.15%浓度的Astepro鼻喷剂和安慰剂分别喷2次于左右鼻腔,每日2次。总体而言,2~4周的临床试验结果表明,与安慰剂相比,患者喷用Astepro后其鼻部症状总评分(TNSS,即鼻漏、鼻充血、喷嚏和鼻痒4个症状评分总和)在整个研究期间显著下降。患者喷用Astepro后鼻部症状迅速缓解,其中一项临床试验中,患者的鼻部症状在30 min后缓解,还有一项的患者在45 min后缓解。

ASTEPRO

Manufacturer:

Meda Pharmaceuticals

Pharmacological Class:

Antihistamine.

Active Ingredient(s):

Azelastine HCl 137mcg/spray; aqueous nasal spray; contains benzalkonium chloride.

Indication(s):

Seasonal allergic rhinitis.

Pharmacology:

Seasonal allergic rhinitis presents as an array of symptoms such as rhinorrhea, nasal congestion, sneezing, and itchy nose caused by sensitivity to seasonal pollens. Azelastine hydrochloride is an antihistamine that antagonizes H1-receptor activity to relieve these symptoms by interfering with the inflammatory response to the allergens. The major active metabolite of azelastine hydrochloride, desmethylazelastine, also possesses H1-receptor antagonist activity.

Clinical Trials:

A 2-week, randomized, multicenter, double-blind, placebo-controlled clinical trial was conducted to establish the safety and efficacy of Astepro nasal spray in the treatment of seasonal allergic rhinitis. In this study, 834 adult and adolescent patients 12–83 years of age with symptoms of seasonal allergic rhinitis were randomized to receive Astepro nasal spray, Astelin nasal spray, or vehicle nasal spray. Efficacy was assessed based on the 12-hour reflective total nasal symptom scores (rTNSS) (rhinorrhea, nasal congestion, sneezing, and nasal itching on a 0 to 3 severity scale [0=absent to 3=severe]) recorded by the patients in the morning (AM) and evening (PM). The primary efficacy endpoint was defined as the mean change from baseline of the summed AM and PM rTNSS for each day (maximum score =24) and averaged over the 2-week treatment period. At endpoint, Astepro nasal spray demonstrated a greater decrease in the summed AM and PM rTNSS compared to placebo and the difference was statistically significant.

Legal Classification:

Rx

Adults:

1 or 2 sprays in each nostril twice daily.

Children:

Not recommended.

Warnings/Precautions:

Avoid eyes, mouth. Pregnancy (Cat.C). Nursing mothers.

Interaction(s):

Potentiates CNS depression with alcohol, other CNS depressants. Serum levels increased by cimetidine. Caution with other antihistamines.

Adverse Reaction(s):

Bitter taste, epistaxis, headache, fatigue, somnolence.

How Supplied:

Spray—30mL (200 sprays)

Last Updated:

3/4/2009

责任编辑:admin


相关文章
爱赛平(盐酸氮卓斯汀鼻喷剂 )
 

最新文章

更多

· KARBINAL ER(马来酸卡比...
· Nasonex Nasal(Mometas...
· Alesion Dry Syrup 1%(...
· Alesion Tablets(Epina...
· Erizas Capsule for Nas...
· GRASTEK(Timothy Grass ...
· LORATADINE OD Film(氯...
· XYZAL(Levocetirizine ...
· RAGWITEK(Short Ragweed...
· EBASTEL(艾巴停片/口腔...

推荐文章

更多

· KARBINAL ER(马来酸卡比...
· Nasonex Nasal(Mometas...
· Alesion Dry Syrup 1%(...
· Alesion Tablets(Epina...
· Erizas Capsule for Nas...
· GRASTEK(Timothy Grass ...
· LORATADINE OD Film(氯...
· XYZAL(Levocetirizine ...
· RAGWITEK(Short Ragweed...
· EBASTEL(艾巴停片/口腔...

热点文章

更多